CRO/Sponsor

Plan ahead for many seasonal diseases that could derail even the best laid clinical trials.

While it has yet to be fully integrated, electronic data capture is gaining ground in Japan.

Economic factors and sponsor practices will dramatically alter the investigative site landscape.

Economical development and regulatory standards make the country a logical choice for trials.

With a PC and some software you can generate realistic projections that save time and money.

The once recession-proof industry must now seek out opportunities to defend itself from potential downfalls.

Evolving out of disconnected technology solutions and working toward integrated processes.

Alleviating clinical trial costs in two pivotal areas with the use of collaborative technology.

A look at how the current financial crisis has established more opportunity for the contract research organization industry.

Today's drug sponsors need to prepare and practice for worst-case clinical trial scenarios.

Using predictive modeling to combat the challenges of study enrollment.

Undertaking clinical studies in this emerging region requires first overcoming natural barriers.

Knowing what you want from a CROs proposal will help make the most of the selection process.

With so much depending on accurate data, taking a do-it-yourself approach to scoring can be risky.

An integrated product development plan designed early increases the odds of on time success.

Improving the quality of radiological measurements in oncology trials with IAs.

Out of necessity, providers may finally become valued strategic partners.

Effective ways for sponsors to reduce risk when embarking on comparative clinical trials.

Study reveals how sponsors rate their own outsourcing abilities compared to other companies.

A more transparent solution to vendor selection in an evolving technology environment.

Two case studies illustrate the potential to turn chaos into meaningful clinical study reports.

Similarities exist, but successful design requires that CROs understand the differences.

What it takes to get all stakeholders on the same page and keep project timelimes on track.

Designing and adapting the latest technology to meet clinical trial needs and redeem the best of its multiple benefits.

Drug development, largely immune to past economic downturns, now faces a different climate.